These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37888097)

  • 1. Role of Adjuvant Radiotherapy in Patients with Cervical Cancer Undergoing Radical Hysterectomy.
    Alonso-Espías M; Gorostidi M; Gracia M; García-Pineda V; Diestro MD; Siegrist J; Hernández A; Zapardiel I
    J Pers Med; 2023 Oct; 13(10):. PubMed ID: 37888097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radical hysterectomy without adjuvant radiotherapy in patients with cervix carcinoma FIGO 2009 IB1, with or without positive Sedlis criteria.
    Haesen J; Salihi R; Van Gorp T; Van Nieuwenhuysen E; Han SN; Christiaens M; Van Rompuy AS; Waumans L; Neven P; Vergote I
    Gynecol Oncol; 2021 Sep; 162(3):539-545. PubMed ID: 34253389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of adjuvant therapy after radical hysterectomy in intermediate-risk, early-stage cervical cancer.
    Cao L; Wen H; Feng Z; Han X; Zhu J; Wu X
    Int J Gynecol Cancer; 2021 Jan; 31(1):52-58. PubMed ID: 33303568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Adjuvant Radiotherapy on Survival Outcomes in Intermediate-Risk, Early-Stage Cervical Cancer: Analyses Regarding Surgical Approach of Radical Hysterectomy.
    Kim SI; Kim TH; Lee M; Kim HS; Chung HH; Lee TS; Jeon HW; Kim JW; Park NH; Song YS
    J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33153125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impacts of minimally invasive surgery on intermediate- or high-risk cervical cancer patients received adjuvant radiotherapy.
    Zhang Q; Liu Z; Wang Y; Zhang J; Li W; Wang T; Wang J; Shi F; Su J
    World J Surg Oncol; 2022 Nov; 20(1):372. PubMed ID: 36443879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of adjuvant radiotherapy on oncological outcomes in patients with early-stage cervical carcinoma with only intermediate-risk factors: a propensity score matching analysis.
    Turkmen O; Kilic F; Tokalioglu AA; Cakir C; Yuksel D; Kilic C; Boran N; Kimyon Comert G; Turan T
    J Obstet Gynaecol; 2022 Oct; 42(7):3204-3211. PubMed ID: 35959796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Stratification of Early-Stage Cervical Cancer with Intermediate-Risk Factors: Model Development and Validation Based on Machine Learning Algorithm.
    Chu R; Zhang Y; Qiao X; Xie L; Chen W; Zhao Y; Xu Y; Yuan Z; Liu X; Yin A; Wang Z; Zhang Q; Yang X; Su X; Kong B; Song K
    Oncologist; 2021 Dec; 26(12):e2217-e2226. PubMed ID: 34427018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of adjuvant radiotherapy after radical hysterectomy in node-negative stage IB-IIA cervical cancer with intermediate risk factors.
    Tuipae S; Yanaranop M; Oniem N
    J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S117-24. PubMed ID: 22619897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment results of adjuvant pelvic radiotherapy after radical hysterectomy for low-risk Stage IB1-IIA cervical cancer.
    Zhao D; Qiu H; Zhang H; Hong L; Zhang G; Xie C
    Jpn J Clin Oncol; 2017 Nov; 47(11):1024-1030. PubMed ID: 28973662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
    Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of isolated loco-regional recurrence rate in intermediate risk early cervical cancer after a type C2 radical hysterectomy without adjuvant radiotherapy.
    van der Velden J; Mom CH; van Lonkhuijzen L; Tjiong MY; Westerveld H; Fons G
    Int J Gynecol Cancer; 2019 May; ():. PubMed ID: 31133601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC Study).
    Nakamura K; Kitahara Y; Satoh T; Takei Y; Takano M; Nagao S; Sekiguchi I; Suzuki M
    World J Surg Oncol; 2016 Jun; 14(1):173. PubMed ID: 27356862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoradiotherapy is not superior to radiotherapy alone after radical surgery for cervical cancer patients with intermediate-risk factor.
    Kim H; Park W; Kim YS; Kim YJ
    J Gynecol Oncol; 2020 May; 31(3):e35. PubMed ID: 31912685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
    Kokka F; Bryant A; Brockbank E; Powell M; Oram D
    Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The issues regarding postoperative adjuvant therapy and prognostic risk factors for patients with stage I-II cervical cancer: A review.
    Takekuma M; Kasamatsu Y; Kado N; Kuji S; Tanaka A; Takahashi N; Abe M; Hirashima Y
    J Obstet Gynaecol Res; 2017 Apr; 43(4):617-626. PubMed ID: 28190285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the pathologic tumor size associated with survival in early cervical cancer treated with radical hysterectomy and adjuvant radiotherapy?
    Cho WK; Park W; Kim H; Kim YJ; Kim YS
    Taiwan J Obstet Gynecol; 2022 Mar; 61(2):329-332. PubMed ID: 35361396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
    Kokka F; Bryant A; Olaitan A; Brockbank E; Powell M; Oram D
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD010260. PubMed ID: 35994243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Extensive Lymphadenectomy in Early-Stage Cervical Cancer Patients With Radical Hysterectomy Followed by Adjuvant Radiotherapy.
    Tomita N; Mizuno M; Kondo S; Mori M; Takeshita S; Sakata J; Tsubouchi H; Kodaira T
    Int J Gynecol Cancer; 2018 Jul; 28(6):1211-1217. PubMed ID: 29727352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic evaluation of postoperative adjuvant therapy for operable cervical cancer: 10 years' experience of National Cancer Center in China.
    Shu T; Zhao D; Li B; Wang Y; Liu S; Li P; Zuo J; Bai P; Zhang R; Wu L
    Chin J Cancer Res; 2017 Dec; 29(6):510-520. PubMed ID: 29353973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Curative effect analysis of postoperative concurrent chemoradiotherapy on early-stage cervical cancer patients with intermediate-risk factors].
    Tang Q; Tu YQ; Chen JH; Lyu XJ; Yan DD
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):462-466. PubMed ID: 29936774
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.